Keyphrases
Preeclampsia
100%
Pregnant Women
41%
Maternal Blood
34%
Placenta
34%
MRNA Expression
19%
Noninvasive Prenatal Diagnosis
18%
Week of Gestation
16%
Cellular Components
15%
Prediction of Preeclampsia
14%
Gene Expression
14%
Preeclamptic
13%
Chorionic Villous
13%
Pre-eclamptic Women
13%
Maternal Plasma
12%
Messenger RNA (mRNA)
11%
Blood Samples
10%
Cell-free mRNA
10%
Quantitative PCR
10%
Placenta-specific Protein 1
9%
Endoglin
9%
Trophoblast
9%
NRBC
9%
DNA Diagnosis
9%
Circulating mRNA
9%
Antioxidant Supplementation
9%
Antioxidant System
9%
Multiple of the Median
8%
Vascular Endothelial Growth Factor Receptor (VEGFR)
7%
Gestational Age
7%
Selectins
7%
Indonesia
7%
Fetal DNA
7%
Vascular Endothelial Growth Factor
7%
Fetal Cells
6%
Peripheral Blood
6%
Plasminogen Activator inhibitor-1 (PAI-1)
6%
Third Trimester
6%
Placental Lactogen
6%
Superoxide Dismutase
6%
Quantitative Distribution
6%
RNA Markers
6%
Placental Tissue
6%
Control Subjects
6%
Messenger RNA Expression
6%
Pregnancy-associated Plasma protein-A (PAPP-A)
6%
Expression Level
5%
Median Value
5%
Jakarta
5%
Fetal DNA in Maternal Plasma
5%
Detection Rate
5%
Medicine and Dentistry
Pre-Eclampsia
70%
Placenta
36%
Maternal Blood
29%
Prenatal Diagnosis
18%
Pregnancy
16%
Maternal Plasma
14%
Cesarean Section
13%
Placenta Accreta
13%
Bleeding
10%
Supplementation
9%
PADGEM Protein
8%
Gestational Age
6%
Plasminogen Activator Inhibitor-1
6%
Vasculotropin
6%
Oxidative Stress
6%
Premature Labor
5%
Cell-Free Fetal DNA
5%
Maternal Serum
5%
Gene Expression
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Vaginal Delivery
5%
Symptom
5%
Third Trimester Pregnancy
5%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
54%
Pregnancy
30%
Gene Expression
19%
Trophoblast
16%
Eclampsia
13%
P-Selectin
12%
VEGF Receptors
12%
Second Trimester Pregnancy
9%
RNA
8%
Oxidative Stress
8%
Angiogenesis
8%
Galactose
7%
Endoglin
7%
Plasminogen Activator Inhibitor-1
7%
Heme Oxygenase
7%
Lectin
6%
Syncytiotrophoblast
6%
Reverse Transcription Polymerase Chain Reaction
6%
Messenger RNA
6%
Fluorescence in Situ Hybridization
6%
Human Placental Lactogen
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Laser Microdissection
5%
Case-Control Study
5%